Orzaks Ilac ve Kimya Sanayi Ticaret A.S.

As of June 30, 2026, Orzaks Ilac ve Kimya Sanayi Ticaret A.S. has 92.10M shares outstanding.

As of June 30, 2026, Orzaks Ilac ve Kimya Sanayi Ticaret A.S. maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 144.36, indicating elevated leverage, while an interest coverage ratio of 0.68 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Orzaks Ilac ve Kimya Sanayi Ticaret A.S. recorded an income tax benefit of -139.03M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

These figures are as of the close on October 22, 2026.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, Orzaks Ilac ve Kimya Sanayi Ticaret A.S. holds 934.71M in cash and equivalents against 5.11B in total debt, resulting in a net debt position of 4.04B. Total book value stands at 3.54B, with working capital of 3.05B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Orzaks Ilac ve Kimya Sanayi Ticaret A.S. posted a gross margin of 66.88, reflecting its pricing power and cost economics. The operating margin of 20.77 and net profit margin of -3.89 provide insight into operational efficiency.